The overall aim of this research is to identify the potential co-occurrence of genomic variants beyond mutations in the SACS gene, and the epigenetic effects that might explain the different phenotype severity existing among ARSACS patients.
Grant : $52,000
Durée : un an
Contact :
Dr. Daniele Galatolo
Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit
IRCCS Stella Maris Foundation
via dei Giacinti 2,
56128 Calambrone (Pisa) - Italy
Email : daniele.galatolo@fsm.unipi.it
